These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 37274238)
1. Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway. Xie F; Zheng Y; Fu W; Chi B; Wang X; Zhang J; Gu J; Yin J; Zhou Q; Guo S; Cai L; Yang J; Liu S; Wang H Front Oncol; 2023; 13():1218781. PubMed ID: 37274238 [TBL] [Abstract][Full Text] [Related]
2. The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells Xie F; Zheng Y; Fu W; Chi B; Wang X; Zhang J; Gu J; Yin J; Zhou Q; Guo S; Cai L; Yang J; Liu S; Wang H Front Oncol; 2023; 13():1138238. PubMed ID: 37182151 [TBL] [Abstract][Full Text] [Related]
3. Suppression of Wnt/β-catenin Signaling in PDAC via METTL16-mediated N6-methyladenosine Modification of DVL2. Yu L; Lu J; Xie N; Fang L; Chen S; Wu Y; Wang X; Li B J Cancer; 2023; 14(16):2964-2977. PubMed ID: 37859814 [TBL] [Abstract][Full Text] [Related]
4. METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis. Ye F; Wu J; Zhang F Biochem Biophys Res Commun; 2023 Jan; 638():1-6. PubMed ID: 36434904 [TBL] [Abstract][Full Text] [Related]
5. METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer. Wang XK; Zhang YW; Wang CM; Li B; Zhang TZ; Zhou WJ; Cheng LJ; Huo MY; Zhang CH; He YL J Cell Mol Med; 2021 Jul; 25(14):6602-6617. PubMed ID: 34075693 [TBL] [Abstract][Full Text] [Related]
6. METTL16-mediated translation of Tang J; Zhao X; Wei W; Liu W; Fan H; Liu XP; Li Y; Wang L; Guo J PeerJ; 2022; 10():e14379. PubMed ID: 36518278 [TBL] [Abstract][Full Text] [Related]
7. METTL16, an evolutionarily conserved m6A methyltransferase member, inhibits the antiviral immune response of miiuy croaker (Miichthys miiuy). Zhao Y; Luo Q; Wang W; Geng S; Sun Y; Xu T Dev Comp Immunol; 2023 Aug; 145():104713. PubMed ID: 37085020 [TBL] [Abstract][Full Text] [Related]
9. The m6A methyltransferase METTL16 negatively regulates MCP1 expression in mesenchymal stem cells during monocyte recruitment. Zhang Z; Xie Z; Lin J; Sun Z; Li Z; Yu W; Zeng Y; Ye G; Li J; Ye F; Su Z; Che Y; Xu P; Zeng C; Wang P; Wu Y; Shen H JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795489 [TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Comprehensive analysis of the transcriptome-wide m6A methylome in lung adenocarcinoma by MeRIP sequencing. Mao W; Yu Q; Wang K; Ma Q; Zheng Y; Zhang G; Luo W; Wang N; Wang Y Front Oncol; 2022; 12():1032295. PubMed ID: 36267960 [TBL] [Abstract][Full Text] [Related]
11. Investigating the mechanism of METTL16-dependent m6A modification regulating the SAMD11 protein signaling pathway to inhibit thyroid cancer phenotypes. Liu Y; Wu G; Tao X; Dong J; Shi T; Shi C Int J Biol Macromol; 2024 Nov; 280(Pt 4):136176. PubMed ID: 39362437 [TBL] [Abstract][Full Text] [Related]
12. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer. Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987 [TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Development and validation of a m Chen Y; Xia L; Peng Y; Wang G; Bi L; Xiao X; Li C; Li W Front Oncol; 2023; 13():1309950. PubMed ID: 38023249 [TBL] [Abstract][Full Text] [Related]
15. Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway. Wen X; Chen S; Chen X; Qiu H; Wang W; Zhang N; Liu W; Wang T; Ding X; Zhang L Front Oncol; 2024; 14():1381151. PubMed ID: 38463236 [TBL] [Abstract][Full Text] [Related]
16. Corrigendum: Doxycycline Inhibits Cancer Stem Cell-Like Properties Liu H; Tao H; Wang H; Yang Y; Yang R; Dai X; Ding X; Wu H; Chen S; Sun T Front Oncol; 2022; 12():830506. PubMed ID: 35280769 [TBL] [Abstract][Full Text] [Related]
17. METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma. Zeng X; Zhao F; Cui G; Zhang Y; Deshpande RA; Chen Y; Deng M; Kloeber JA; Shi Y; Zhou Q; Zhang C; Hou J; Kim W; Tu X; Yan Y; Xu Z; Chen L; Gao H; Guo G; Liu J; Zhu Q; Cao Y; Huang J; Wu Z; Zhu S; Yin P; Luo K; Mer G; Paull TT; Yuan J; Tao K; Lou Z Nat Cancer; 2022 Sep; 3(9):1088-1104. PubMed ID: 36138131 [TBL] [Abstract][Full Text] [Related]
18. METTL16 in human diseases: What should we do next? Zhang H; Yin M; Huang H; Zhao G; Lu M Open Med (Wars); 2023; 18(1):20230856. PubMed ID: 38045858 [TBL] [Abstract][Full Text] [Related]
19. m6A Methyltransferase 3 Promotes the Proliferation and Migration of Gastric Cancer Cells through the m6A Modification of YAP1. Zhou W; Xian Q; Wang Q; Wu C; Yan H; Li X; Lu L; Wu C; Zhu D; Xu X; Wu J J Oncol; 2021; 2021():8875424. PubMed ID: 34394353 [TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Systematic characterization of the clinical relevance of KPNA4 in pancreatic ductal adenocarcinoma. Bao J; Xu C; Li B; Wu Z; Shen J; Song P; Peng Q; Hu G Front Oncol; 2023; 13():1282120. PubMed ID: 37766865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]